- Home
- ELVN vs VRE Comparison
ELVN vs VRE Comparison
Compare ELVN & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | VRE |
|---|---|---|
| Founded | 2016 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ELVN | VRE |
|---|---|---|
| Price | $30.83 | $18.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $41.00 | $18.67 |
| AVG Volume (30 Days) | 758.9K | ★ 2.6M |
| Earning Date | 03-03-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.70% |
| EPS Growth | 3.17 | ★ 420.00 |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | ★ $288,434,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.87 |
| P/E Ratio | ★ N/A | $23.62 |
| Revenue Growth | N/A | ★ 6.40 |
| 52 Week Low | $13.30 | $13.69 |
| 52 Week High | $31.76 | $18.91 |
Technical Indicators
Market Signals| Indicator | ELVN | VRE |
|---|---|---|
| Relative Strength Index (RSI) | 60.06 | 79.32 |
| Support Level | $16.92 | $14.43 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.92 | 0.04 |
| MACD | -0.07 | -0.12 |
| Stochastic Oscillator | 76.95 | 95.45 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.